Medication info

Acirobide-Tab (Acyclovir)

Prescription medicationExpired
Ingredient · strength
Acyclovir›Strength being verified
Manufacturer / importer
Dong-gu Bio Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
Bottle - 21 tablets/bottle
Approval status
Expired

MFDS item code 200401502 · Notified 2004.11.23

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, treatment should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at intervals of approximately 6 hours. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at intervals of approximately 6 hours. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at intervals of approximately 4 hours, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal absorption disorders. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more susceptible to adverse neuropsychiatric reactions, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose should generally not exceed the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is advisable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is advisable to reduce the dose to 800 mg of this medicine per dose twice daily at intervals of approximately 12 hours. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is advisable to reduce the dose to 800 mg of this medicine per dose 3 times daily at intervals of approximately 8 hours.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as the adult dosage. Under 2 years of age: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Dong-gu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children

  • Primary genital herpes
  • recurrent genital herpes
  • skin herpes simplex virus infections
  • mucosal herpes simplex virus infections
  • herpes zoster virus infections
  • acute herpes zoster pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections that occur on the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in the treatment of herpes zoster virus infections and particularly helps alleviate acute pain. However, please note that its effectiveness against postherpetic neuralgia has not yet been conclusively proven. Additionally, it is used to treat chickenpox in children over two years of age. Overall, this drug is useful for treating various viral infections and improving symptoms.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection; in recurrent cases, treatment should preferably begin when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at intervals of approximately 6 hours. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily, after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at intervals of approximately 6 hours. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal absorption disorders, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at intervals of approximately 4 hours, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal absorption disorders. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more susceptible to adverse neuropsychiatric reactions, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose should generally not exceed the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is advisable to administer 200 mg of this medicine every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is advisable to reduce the dose to 800 mg of this medicine per dose twice daily at intervals of approximately 12 hours. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is advisable to reduce the dose to 800 mg of this medicine per dose 3 times daily at intervals of approximately 8 hours.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as the adult dosage. Under 2 years of age: Administer 1/2 of the adult dose. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medication should not be used in patients who have had allergic reactions to this drug or its components, as well as to valacyclovir. Caution is needed when administering to patients with impaired kidney function, as the likelihood of central nervous system adverse reactions may be increased. Patients with liver impairment should use this drug with caution as it may further worsen liver function. In infants and children, it should be administered minimally only when necessary, and care should be taken with neonates or low birth weight infants, as safety has not been established. Elderly patients may have diminished renal function, which could lead to increased blood concentrations of this drug and a higher risk of adverse reactions, requiring careful adjustment of dosage and intervals. During administration of this drug, rare but serious allergic reactions such as anaphylactic shock may occur, so patients should be closely monitored. If symptoms such as hypotension, difficulty breathing, or chest tightness occur, administration should be discontinued immediately and appropriate treatment should be sought. Photosensitivity reactions or hypersensitive reactions such as skin rashes, fever, vesicles, and urticaria may occur; if these symptoms are observed, administration should be stopped. Skin-related adverse reactions such as hair loss, erythema multiforme, severe skin conditions such as Stevens-Johnson syndrome or Lyell's syndrome may occur, thus caution is warranted. Neurological symptoms may include consciousness disturbances, spatial disorientation, impaired concentration, aggressive behavior, confusion, hallucinations, seizures, drowsiness, anxiety, etc., especially in the elderly or patients with impaired renal function, where these may occur more frequently. Renal issues such as renal failure, hematuria, and proteinuria may develop; hence, kidney status should be carefully observed. Hematologic and lymphatic abnormalities may present as leukopenia, anemia, bleeding, or purpura, so regular blood tests are advisable. Liver function abnormalities may manifest as hepatitis, jaundice, or elevated liver function tests, requiring careful monitoring of liver status. Gastrointestinal symptoms such as gastritis, nausea, vomiting, diarrhea, and abdominal pain may occur; should symptoms develop, administration should be reconsidered. Systemic symptoms may include fever, swelling, muscle weakness, and headache. Musculoskeletal issues may involve joint pain and myalgia. Cardiovascular problems may present as arrhythmias, blood pressure changes, and palpitations, therefore cardiac status should be monitored. Urinary issues may include difficulty urinating or urinary obstruction. This drug is effective when administered soon after the onset of symptoms during herpes simplex or chickenpox treatment; for shingles, it should be started within 5 days after skin symptoms appear, and for chickenpox, within 3 days is preferable. Patients with impaired immune function might need intravenous formulations. Adequate hydration is necessary during the treatment period to reduce risks of dehydration and renal toxicity. In treating recurrent genital herpes, it should only be used in patients with repeat outbreaks, and the decision to continue treatment should be evaluated after one year. This medication may cause consciousness disturbances, hence caution is required during driving or operating hazardous machinery. Interactions may occur when taken with other drugs, especially those affecting kidney function or specific medications, increasing the risk of renal impairment, hence caution is advised. Women who are pregnant or may become pregnant should use this medication only when the benefits outweigh the risks, and since the components of this drug are found in breast milk, breastfeeding should be discontinued while on treatment. In cases of overdose, serious side effects such as agitation, stupor, seizures, and renal failure may occur, necessitating immediate medical observation and appropriate treatment.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • impaired concentration
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • epigastric pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • indigestion
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • low blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • alopecia
  • sweating
  • hyponatremia
  • decreased serum protein
  • increased total cholesterol levels
  • elevated triglycerides
  • increased serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • convulsions
  • hypotonia
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or humidity, so it must be stored in a tightly closed container. It is best to keep it at room temperature between 15 and 25 degrees Celsius. This will help maintain the drug's efficacy and safety over time.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

Bottle - 21 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.